🌟2025 is looking bright! Today, we announced that AlphaSense has surpassed $400M in ARR and is now bringing our cutting-edge AI search capabilities to over 6,000 businesses. It has been an incredible year of milestones, from our acquisition of @TegusHQ and increasing our

A key debate happening right now: .Based on ASCO 2025 data, what is the adoption outlook for $AZN's camizestrant in ESR1-mutated breast cancer?. Some background:.AstraZeneca presented positive SERENA-6 trial data for camizestrant in HR+, HER2- metastatic breast cancer patients

RT @WonderBotz: Self-doubt is something many professionals quietly wrestle with. As part of our Women’s Week Webinar Series, Toni Iafrate,….

If you are interested in more interviews like this one, make sure to follow us!. The full interview can be found here ⤵️.

Former $ORCL employee explains how deals are made between $ORCL and their partners:. - The expert emphasized that $ORCL typically expects heavy upfront discounts in reseller partnerships. The expert noted, based on experience at $ORCL and $SAP, that discounts can start as high as

In the first half of 2025, generative AI has changed dramatically. Established companies have consolidated their leads, but new players are shaking up the market. As models become more powerful and investment in infrastructure accelerates, organizations are starting to cut

Olo Enters into Definitive Agreement to be Acquired by Thoma Bravo. "Olo Inc. (NYSE: $OLO) (“Olo” or the “Company”), a leading open SaaS platform for restaurants, today announced that it has entered into a definitive agreement to be acquired by Thoma Bravo, a leading software

Key Takeaways from $STZ's Earnings Call. Key Financial Results:.- Q1 performance was in line with company expectations. - One less selling day in Q1 compared to prior year. - Q1 saw depletion declines similar to Q4 when adjusted for one less day. Business Segment Results:.- Beer

If you are interested in more interviews like this one, make sure to follow us!. The full interview can be found here ⤵️.

Interview with an industry expert on AI-driven ROI in advertising ( $META, $GOOGL, $SNAP, $MSFT, $AMZN ):. - The expert emphasized that AI is now central to digital advertising strategy, particularly in social and retail media. $META's Advantage+ campaigns, powered by machine

Key Takeaways from $UNF's Earnings Call. Key Financial Results:.- Q3 2025 consolidated revenues were $610.8 million, up 1.2% from prior year. - Net income increased to $39.7 million ($2.13 per diluted share) from $38.1 million ($2.03 per diluted share). - Consolidated adjusted

Design software company Figma filed for an IPO on Tuesday. In May, we published a primer discussing how experts broadly believe Figma is better positioned to go public than some of its peers, thanks to a strong product suite that it continues to expand.

Key Takeaways from $GBX's Earnings Call. Key Financial Results:.- Revenue of $843 million, up 11% sequentially. - Net earnings of $60.1 million or $1.86 per share. - Aggregate gross margin of 18%, marking seventh consecutive quarter at/above mid-teens target. - Operating income

JPMorganChase Plans Dividend Increase and Has Authorized a New Common Share Repurchase Program. "JPMorgan Chase & Co. (NYSE: $JPM) (“JPMorganChase” or the “Firm”) announced today that its Board of Directors intends to increase the quarterly common stock dividend to $1.50 per

$F Second Quarter Sales Rise 14.2%; Market Share Surges on Truck, Hybrid, SUV Strength. "Ford Motor Company accelerated well ahead of the U.S. industry in the second quarter, growing sales 14.2% — about 10 times the estimated 1.4% industry increase — and expanding market share to

If you are interested in more interviews like this one, make sure to follow us!. The full interview can be found here ⤵️.

An employee at Hugging Face shares insights on small language models and their use in robotics ( $GOOGL, $NVDA, $TSLA ):. - The expert emphasized that while SmolVLA is relatively small, with 450 million parameters, it aligns with what top robotics players like Figure, 1X, and

Once dominated by Red Bull and Monster, the U.S. energy drink market is shifting as sugar-free options now drive over half of sales. Newcomers like Celsius are now holding 10%+ market share and now shaking up the space. Want to know what's behind this shift? In our latest

Watch Sara Mallatt, AlphaSense’s Director of Healthcare Research, and Dr. Paul Agapow, former Director of Data Science at GSK, as they explore how AI is tackling today’s biggest opportunities and challenges in drug discovery and development and where the field is headed. In this

If you are interested in more interviews like this one, make sure to follow us!. The full interview can be found here ⤵️.